The effects of Batroxobin on the intimal hyperplasia of graft veins

American Journal of Surgery

Volumn 206, Issue 4, 2013, Pages 594-598

  Liu, Wenguang ^a   Wang, Jian ^b   Chen, Cheng ^c   Zhou, Fan ^b   Zhou, Yan ^b   Zhang, Fangjie ^b  

^a LINYI PEOPLE'S HOSPITAL   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c People's Hospital of Zhoushan City   (China)

Author keywords

Autologous veins graft Batroxobin Intimal hyperplasia

Indexed keywords

BATROXOBIN; CYCLINE; ENDOTHELIN 1; MYC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; FEMORAL VEIN; GRAFT VEIN INTIMAL HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VEIN GRAFT; VEIN GRAFT DISEASE;

AUTOLOGOUS VEINS GRAFT; BATROXOBIN; INTIMAL HYPERPLASIA;

ANIMALS; BATROXOBIN; CELL PROLIFERATION; DOGS; ENDOTHELIN-1; FEMORAL ARTERY; FEMORAL VEIN; FIBRINOLYTIC AGENTS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MICROSURGERY; MODELS, ANIMAL; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC; RANDOM ALLOCATION; TRANSPLANTATION, AUTOLOGOUS; TUNICA INTIMA; TUNICA MEDIA;

EID: 84885029527     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2012.12.010     Document Type: Article

References (27)

1. J. Hu, and S. Wan External support in preventing vein graft failure Asian Cardiovasc Thorac Ann 20 2012 615 622
2. M. Belkin, J. Knox, and M.C. Donaldson Infrainguinal arterial reconstruction with nonreversed greater saphenous vein J Vasc Surg 24 1996 957 962
3. R. Ross The pathogenesis of arteriosclerosis: a perspective for the 1990s Nature 362 1993 801 809
4. K. Stocker, H. Fischer, and J. Meier Thrombin-like snake venom proteinases Toxicon 20 1982 265 273
5. S. Braud, C. Bon, and A. Wisner Snake venom proteins acting on hemostasis Biochimie 82 2000 851 859
6. W.R. Bell Jr. Defibrinogenating enzymes Drugs 54 Suppl 3 1997 18 30
7. C.E. Dempfle, S. Argiriou, and K. Kucher Analysis of fibrin formation and proteolysis during intravenous administration of ancrod Blood 96 2000 2793 2802
8. Q.B. Song, M.J. Wei, and Z.Q. Duan Batroxobin reduces intracellular calcium concentration and inhibits proliferation of vascular smooth muscle cells Chin Med J (Engl) 117 2004 917 921
9. D.S. Wang, M. Hanamoto, and F. Fang Defibrinogenating effect of batroxobin (defibrase) in rats and inhibition of migration of human vascular smooth muscle cells by the plasma of batroxobin-treated rats in vitro Atherosclerosis 156 2001 73 80
10. A.C. Newby, and S.J. George Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies Cardiovasc Res 27 1993 1173 1183
11. J.L. Shu, Z.S. Jiang, and C.S. Tang Study of Batroxobin for its vascular dilation effect and the mechanism Chin Pharmacol Bull (Chin) 14 1998 229 231
12. P.G. Kuang, F.Y. Zhang, and Z.Z. Li Effect of batroxobin (DF-521) on vasopressin in ischemic gerbils J Clin Neurol 8 1995 261
13. W.P. Wu, Z.Z. Li, and P.G. Kuang Effect of batroxobin on c-fos gene expression in ischemic reperfusion rats J Apopl Nerv Dis 12 1995 73
14. R.D. Wood, and M.K.K. Shivji Which DNA polymerases are used for DNA-repair in eukaryotes? Carcinogenesis 18 1997 605 610
15. C. Bouchard, P. Staller, and M. Eilers Control of cell proliferation by Myc Trends Cell Biol 8 1998 202 206
16. C.A. Spencer, and M. Groudine Control of c-myc regulation in normal and neoplastic cells Adv Cancer Res 56 1991 1 48
17. L.M. Facchini, and L.Z. Penn The molecular role of Myc in growth and transformation: recent discoveries lead to new insights FASEB J 12 1998 633 651
18. C. Grandori, S.M. Cowley, and L.P. James The Myc/Max/Mad network and the transcriptional control of cell behavior Annu Rev Cell Dev Biol 16 2000 653 699
19. M.G. Davies, and P.O. Hagen Pathobiology of intimal hyperplasia Br J Surg 81 1995 1254 1269
20. M. Yanagisawa, H. Kurihara, and S. Kimura A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
21. S.M. Kanse, E. Wijelath, and C. Kanthou The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density Lab Invest 72 1995 376 382
22. C.P. Sung, A.J. Arleth, and B.L. Storer Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle J Pharmacol Exp Ther 271 1994 429 437
23. M. Kyaw, M. Yoshizumi, and K. Tsuchiya Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1) Biochem Pharmacol 64 2002 1521 1531
24. S. Wedgwood, R.W. Dettman, and S.M. Black ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species Am J Physiol Lung Cell Mol Physiol 281 2001 L1058 L1067
25. Y. Kawanabe, Y. Okamoto, and N. Hashimoto Characterization of Ca2+ channels involved in endothelin-1-induced mitogenic responses in vascular smooth muscle cells Eur J Pharmacol 422 2001 15 21
26. T. Tomaru, F. Nakamura, and N. Aoki Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries Heart Vessels 11 1996 133 144
27. T. Tomaru, Y. Fujimori, and T. Morita Local delivery of antithrombotic drug prevents restenosis after balloon angioplasty in atherosclerotic rabbit artery Jpn Circ J 60 1996 981 992